This indicates that the GR and its physiological ligands provide a protective function against the dystrophic disease processes in DMD, in contrast to its role in certain other disease states featuring muscle atrophy or inflammatory muscle wasting. Here, NR3C1 is linked to glycogen storage disease VI.